ATE471342T1 - Parathyroidhormon analoge - Google Patents

Parathyroidhormon analoge

Info

Publication number
ATE471342T1
ATE471342T1 AT05026436T AT05026436T ATE471342T1 AT E471342 T1 ATE471342 T1 AT E471342T1 AT 05026436 T AT05026436 T AT 05026436T AT 05026436 T AT05026436 T AT 05026436T AT E471342 T1 ATE471342 T1 AT E471342T1
Authority
AT
Austria
Prior art keywords
analogue
hormon
parathyroid
parathyroid hormon
hormon analogue
Prior art date
Application number
AT05026436T
Other languages
English (en)
Inventor
Zheng Xin Dong
Original Assignee
Ipsen Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/779,768 external-priority patent/US5969095A/en
Application filed by Ipsen Pharma filed Critical Ipsen Pharma
Application granted granted Critical
Publication of ATE471342T1 publication Critical patent/ATE471342T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT05026436T 1997-01-07 1997-12-08 Parathyroidhormon analoge ATE471342T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/779,768 US5969095A (en) 1995-07-13 1997-01-07 Analogs of parathyroid hormone
US08/813,534 US5955574A (en) 1995-07-13 1997-03-07 Analogs of parathyroid hormone

Publications (1)

Publication Number Publication Date
ATE471342T1 true ATE471342T1 (de) 2010-07-15

Family

ID=27119618

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05026436T ATE471342T1 (de) 1997-01-07 1997-12-08 Parathyroidhormon analoge
AT97951595T ATE321784T1 (de) 1997-01-07 1997-12-08 Pthrp analogen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT97951595T ATE321784T1 (de) 1997-01-07 1997-12-08 Pthrp analogen

Country Status (23)

Country Link
US (1) US5955574A (de)
EP (3) EP2206725A1 (de)
JP (1) JP3963482B2 (de)
KR (2) KR100699422B1 (de)
CN (1) CN1137898C (de)
AR (3) AR011517A1 (de)
AT (2) ATE471342T1 (de)
AU (1) AU741584B2 (de)
BR (1) BR9714200A (de)
CA (1) CA2276614C (de)
CZ (2) CZ298937B6 (de)
DE (2) DE69735603T2 (de)
DK (2) DK0948541T3 (de)
ES (2) ES2258286T3 (de)
HU (1) HUP9904596A3 (de)
IL (1) IL130794A0 (de)
NO (1) NO993341L (de)
NZ (1) NZ336610A (de)
PL (1) PL191898B1 (de)
PT (2) PT1645566E (de)
RU (1) RU2198182C2 (de)
SI (2) SI0948541T1 (de)
WO (1) WO1998030590A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
BR9812068A (pt) * 1997-09-09 2000-09-26 Hoffmann La Roche Processo para a cicatrização óssea e restauração de fraturas e utilização de um análogo de polipeptìdeo de peptìdeo (pthrp) relacionado com hormÈnios de paratireóide e seus sais
AU3673699A (en) * 1998-05-05 1999-11-23 Beth Israel Deaconess Medical Center Pth2 receptor selective compounds
DE69941708D1 (de) * 1998-07-20 2010-01-07 Ipsen Pharma Pacap-peptidanaloga
US6660843B1 (en) † 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
AU2000265051A1 (en) 2000-02-18 2001-08-27 Dabur Research Foundation Vasoactive intestinal peptide analogs
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
JP5073153B2 (ja) 2001-06-01 2012-11-14 ノバルティス アーゲー 副甲状腺ホルモンおよびカルシトニンの経口投与
US7572765B2 (en) 2001-07-23 2009-08-11 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
JP2007501241A (ja) * 2003-08-06 2007-01-25 ローディア インコーポレイティド 骨成長を促進する方法
WO2007059470A2 (en) 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
DK2073789T3 (da) * 2006-10-03 2019-08-05 Radius Health Inc Stabil sammensætning omfattende et knogle-anabolisk protein, nemlig en pthrp-analog, og anvendelser deraf
SI2084183T1 (sl) * 2006-10-13 2010-09-30 Lilly Co Eli Pegilirani pth kot modulatorji pth receptorja in njihove uporabe
BRPI0814962B8 (pt) 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
WO2011071480A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
PL2568806T3 (pl) 2010-05-12 2017-03-31 Radius Health, Inc. Schematy lecznicze
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用
AU2011312490B2 (en) 2010-09-28 2015-06-25 Radius Pharmaceuticals, Inc. Selective androgen receptor modulators
ES2939940T3 (es) 2014-03-28 2023-04-28 Univ Duke Tratamiento del cáncer de mama utilizando moduladores selectivos de los receptores de estrógenos
MX384605B (es) 2015-04-29 2025-03-14 Radius Pharmaceuticals Inc Combinación de palbociclib y rad1901 para usarse en el tratamiento de cáncer de mama en un sujeto con cáncer positivo a receptor de estrógeno.
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
WO2017223115A1 (en) 2016-06-22 2017-12-28 Radius Health, Inc. Ar+ breast cancer treatment methods
EP3565542B1 (de) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphe formen von rad1901-2hcl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
SG11202013177WA (en) 2018-07-04 2021-01-28 Radius Pharmaceuticals Inc Polymorphic forms of rad 1901-2hcl
US12441745B2 (en) 2019-02-12 2025-10-14 Radius Pharmaceuticals, Inc. Processes and compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
EP0293158A3 (de) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroide Hormon-Antagonisten
WO1990010067A1 (de) * 1989-02-23 1990-09-07 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Pth-varianten kodierende dna-sequenzen, pth-varianten, expressionsvektor, bakterieller wirt, verwendung und therapeutische zusammensetzung
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1993006846A1 (en) * 1991-10-10 1993-04-15 Pang Peter K T Parathyroid hormone analogues and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
PL174772B1 (pl) 1993-01-06 1998-09-30 Kinerton Ltd Kompozycja farmaceutyczna zawierająca jonowy konjugat cząsteczkowy
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
EP0800405A4 (de) * 1994-12-19 1998-11-11 Beth Israel Hospital Kontinuierliche niedrigdosierte verabreichung von parathyroidhormon oder deren agonist
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
JP2001508439A (ja) 2001-06-26
AR051906A2 (es) 2007-02-14
WO1998030590A2 (en) 1998-07-16
IL130794A0 (en) 2001-01-28
JP3963482B2 (ja) 2007-08-22
CA2276614C (en) 2002-06-11
DK1645566T3 (da) 2010-09-27
EP0948541A2 (de) 1999-10-13
EP0948541B1 (de) 2006-03-29
AR038552A2 (es) 2005-01-19
NO993341L (no) 1999-09-06
CN1254347A (zh) 2000-05-24
BR9714200A (pt) 2000-03-28
US5955574A (en) 1999-09-21
ATE321784T1 (de) 2006-04-15
DE69735603T2 (de) 2006-11-30
EP1645566A2 (de) 2006-04-12
EP1645566B1 (de) 2010-06-16
CA2276614A1 (en) 1998-07-16
KR100699422B1 (ko) 2007-03-28
HUP9904596A1 (hu) 2000-06-28
PT1645566E (pt) 2010-08-31
WO1998030590A3 (en) 1998-12-10
HK1026215A1 (en) 2000-12-08
NO993341D0 (no) 1999-07-06
PL191898B1 (pl) 2006-07-31
DE69735603D1 (de) 2006-05-18
KR20060030006A (ko) 2006-04-07
AU5519998A (en) 1998-08-03
PT948541E (pt) 2006-07-31
ES2347154T3 (es) 2010-10-26
PL334438A1 (en) 2000-02-28
HUP9904596A3 (en) 2000-07-28
CZ298937B6 (cs) 2008-03-19
EP1645566A3 (de) 2006-10-11
WO1998030590A9 (en) 1999-08-19
CZ239899A3 (cs) 2000-01-12
KR20000069952A (ko) 2000-11-25
KR100497709B1 (ko) 2005-06-23
AR011517A1 (es) 2000-08-30
DE69739912D1 (de) 2010-07-29
NZ336610A (en) 2001-07-27
EP2206725A1 (de) 2010-07-14
ES2258286T3 (es) 2006-08-16
AU741584B2 (en) 2001-12-06
CN1137898C (zh) 2004-02-11
RU2198182C2 (ru) 2003-02-10
SI0948541T1 (sl) 2006-06-30
DK0948541T3 (da) 2006-07-17
SI1645566T1 (sl) 2010-11-30
CZ301497B6 (cs) 2010-03-24

Similar Documents

Publication Publication Date Title
EE03801B1 (xx) Stent
DE69822774D1 (de) Armbanduhr
ID22500A (id) Turunan sulfonamida
DE69727617D1 (de) Stent
DE69731164D1 (de) Stent
ATE321784T1 (de) Pthrp analogen
ID23173A (id) Turunan pirol trisiklik atau pirazol
DE69730774D1 (de) Vitamin D3 Analoge
DE69831377D1 (de) Schutzbalg
DE69812435D1 (de) Fördervorrichtung
DE69917011D1 (de) Handgelenkprothese
DE69711099D1 (de) Projektor
DE59712120D1 (de) Kommunikationseinrichtung
ID20979A (id) Pesawat penggerak piringan
DE69814269D1 (de) Prothesenanordnung
FR2767673B1 (fr) Prothese uretrale
ATE238278T1 (de) Fluorinierte vitamin d3 analoge
DE69718378D1 (de) Analoge FIFO-Speicher
DE59812757D1 (de) Substituierte tetrahydro-naphtaline und analoge verbindungen
DE69810665D1 (de) Analoguhr
ID20763A (id) Mesin tenun
FI971344A0 (fi) En vattenavlaegsningsanordning foer en former
FR2758079B1 (fr) Implant intra-corneen
FI103716B1 (fi) Salibandymaila
KR970058324U (ko) 컨베이어

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1645566

Country of ref document: EP